Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.8%

1 terminated out of 26 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed with results

Key Signals

1 with results92% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (9)
P 2 (4)
P 4 (1)

Trial Status

Completed12
Unknown10
Recruiting2
Terminated1
Active Not Recruiting1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT02072616Not ApplicableTerminatedPrimary

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

NCT07260370Recruiting

The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy

NCT06488365Not ApplicableRecruiting

In Vivo Liquid Biopsy of Melanoma (Cytophone)

NCT06068348Active Not Recruiting

Liquid Biopsy Collection Study

NCT01015625Not ApplicableCompleted

Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer

NCT03340844Not ApplicableCompleted

Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors

NCT03381326Unknown

CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.

NCT04972461UnknownPrimary

Therapeutic Response Evaluation by CTC Expansion System

NCT02449837CompletedPrimary

Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy

NCT05502458Phase 2Completed

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

NCT03101046Phase 2Completed

Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic

NCT02781025CompletedPrimary

Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease

NCT02955173Not ApplicableCompletedPrimary

Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer

NCT02808884Not ApplicableCompletedPrimary

Cancer DNA Screening Pilot Study (CANDACE)

NCT04239105Unknown

Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device

NCT04229121Unknown

Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients

NCT02499458Completed

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

NCT02335151Phase 4Completed

CTC Pancreatic Adenocarcinoma

NCT01548677Phase 2Completed

Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer

NCT03156777UnknownPrimary

Application Value of CTCs Detection for Advanced Gastric Cancer Patients

Scroll to load more

Research Network

Activity Timeline